210 related articles for article (PubMed ID: 21234612)
1. Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma.
Shibuya M; Kondo F; Sano K; Takada T; Asano T
J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):537-43. PubMed ID: 21234612
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma: the second report: relationship with tumor size and cell differentiation.
Kumagai A; Kondo F; Sano K; Inoue M; Fujii T; Hashimoto M; Watanabe M; Soejima Y; Ishida T; Tokairin T; Saito K; Sasajima Y; Takahashi Y; Uozaki H; Fukusato T
J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):414-21. PubMed ID: 27161394
[TBL] [Abstract][Full Text] [Related]
3. Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence.
Zhang F; Chen XP; Zhang W; Dong HH; Xiang S; Zhang WG; Zhang BX
Histopathology; 2008 Jan; 52(2):224-32. PubMed ID: 18184271
[TBL] [Abstract][Full Text] [Related]
4. Morphometric and immunohistochemical study of cholangiolocellular carcinoma: comparison with non-neoplastic cholangiole, interlobular duct and septal duct.
Maeno S; Kondo F; Sano K; Takada T; Asano T
J Hepatobiliary Pancreat Sci; 2012 May; 19(3):289-96. PubMed ID: 22179577
[TBL] [Abstract][Full Text] [Related]
5. Immunohistologic attempt to find carcinogenesis from hepatic progenitor cell in hepatocellular carcinoma.
Yamamoto T; Uenishi T; Ogawa M; Ichikawa T; Hai S; Sakabe K; Tanaka S; Kato H; Mikami S; Ikebe T; Tanaka H; Ito S; Kaneda K; Hirohashi K; Kubo S
Dig Surg; 2005; 22(5):364-70. PubMed ID: 16374007
[TBL] [Abstract][Full Text] [Related]
6. Hepatic progenitor cells in liver cancers from Asian children.
Ward SC; Thung SN; Lim KH; Tran TT; Hong TK; Hoang PL; Jang JJ; Park YN; Abe K
Liver Int; 2010 Jan; 30(1):102-11. PubMed ID: 19793197
[TBL] [Abstract][Full Text] [Related]
7. Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.
Kim H; Choi GH; Na DC; Ahn EY; Kim GI; Lee JE; Cho JY; Yoo JE; Choi JS; Park YN
Hepatology; 2011 Nov; 54(5):1707-17. PubMed ID: 22045674
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic value of absent ductular reaction at hepatocellular-stromal boundaries in early stage hepatocellular carcinoma].
Zhang Q; Ma Z; Xin Q; Liu GQ; Liu BB; Gao YT; Zhang CS; Du Z
Zhonghua Gan Zang Bing Za Zhi; 2013 Dec; 21(12):924-8. PubMed ID: 24636295
[TBL] [Abstract][Full Text] [Related]
9. Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype.
Kim H; Park C; Han KH; Choi J; Kim YB; Kim JK; Park YN
J Hepatol; 2004 Feb; 40(2):298-304. PubMed ID: 14739102
[TBL] [Abstract][Full Text] [Related]
10. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin.
Durnez A; Verslype C; Nevens F; Fevery J; Aerts R; Pirenne J; Lesaffre E; Libbrecht L; Desmet V; Roskams T
Histopathology; 2006 Aug; 49(2):138-51. PubMed ID: 16879391
[TBL] [Abstract][Full Text] [Related]
11. MRI features of hepatocellular carcinoma expressing progenitor cell markers.
Jeong HT; Kim MJ; Kim YE; Park YN; Choi GH; Choi JS
Liver Int; 2012 Mar; 32(3):430-40. PubMed ID: 22097930
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic implication of hepatic progenitor cell marker expression in hepatoblastoma.
Yun WJ; Shin E; Lee K; Jung HY; Kim SH; Park YN; Yu E; Jang JJ
Pathol Res Pract; 2013 Sep; 209(9):568-73. PubMed ID: 23920322
[TBL] [Abstract][Full Text] [Related]
13. Fibrolamellar hepatocellular carcinoma: an immunohistochemical comparison with conventional hepatocellular carcinoma.
Abdul-Al HM; Wang G; Makhlouf HR; Goodman ZD
Int J Surg Pathol; 2010 Oct; 18(5):313-8. PubMed ID: 20444731
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical characteristics of hepatocellular carcinoma in non-cirrhotic livers.
Witjes CD; ten Kate FJ; Verhoef C; de Man RA; IJzermans JN
J Clin Pathol; 2013 Aug; 66(8):687-91. PubMed ID: 23585667
[TBL] [Abstract][Full Text] [Related]
15. Histologic characteristics and prognostic significance in small hepatocellular carcinoma with biliary differentiation: subdivision and comparison with ordinary hepatocellular carcinoma.
Aishima S; Nishihara Y; Kuroda Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
Am J Surg Pathol; 2007 May; 31(5):783-91. PubMed ID: 17460464
[TBL] [Abstract][Full Text] [Related]
16. The best immunohistochemical panel for differentiating hepatocellular carcinoma from metastatic adenocarcinoma.
Karabork A; Kaygusuz G; Ekinci C
Pathol Res Pract; 2010 Aug; 206(8):572-7. PubMed ID: 20400233
[TBL] [Abstract][Full Text] [Related]
17. Hypervascular hepatocellular carcinomas showing hyperintensity on hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging: a possible subtype with mature hepatocyte nature.
Yoneda N; Matsui O; Kitao A; Kita R; Kozaka K; Koda W; Kobayashi S; Gabata T; Ikeda H; Nakanuma Y
Jpn J Radiol; 2013 Jul; 31(7):480-90. PubMed ID: 23771695
[TBL] [Abstract][Full Text] [Related]
18. Primary liver carcinoma arising in people younger than 30 years.
Klein WM; Molmenti EP; Colombani PM; Grover DS; Schwarz KB; Boitnott J; Torbenson MS
Am J Clin Pathol; 2005 Oct; 124(4):512-8. PubMed ID: 16146811
[TBL] [Abstract][Full Text] [Related]
19. Occurrence of c-kit+ tumor cells in hepatitis B virus-associated hepatocellular carcinoma.
Lee ES; Han EM; Kim YS; Shin BK; Kim CH; Kim HK; Won NH; Yeom BW; Kim I; Leong AS
Am J Clin Pathol; 2005 Jul; 124(1):31-6. PubMed ID: 15923163
[TBL] [Abstract][Full Text] [Related]
20. [Preliminary research of hepatocarcinoma stem cell markers].
Yan Z; Fang CH; Gao P
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1304-6. PubMed ID: 16982441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
